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USEFULNESS OF SURVEILLANCE ENDOMYOCARDIAL BIOPSY 
ARDIAC TRANSPLANTATION 
R. Morton Bolman. 111. Sara Shumway. W. 
Steves Rine. Maria’?. Olivari and Raouf E. Nakhlch. University 
490 of Minnesota. Minneiapolis, MN 
ELEVATED PULMONARY VASCULAR RESISTANCE AND CARDIAC 
‘IRANSPLANTATION ARE LARGER DONORS BFITER’ 
Endomyocardial biopsy (BX) remains the gold standard for the 
diagnosis of acute rejection after cardiac transplantation 
(CTX) but few guidelines exist to determine the indications for 
BX in pediatric cardiac transplant recipients. To determine 
the usefulness of surveillance BX, we reviewed 176 BXS 
obtained in 12 patients, aged 0.5 - 16 (avg 9.7) years, 
maintained on cyclosporin, azathioprine and prednisone 
immunosuppression, and followed 2.8 - 45.5 (avg 19.3) months 
after CTX. Childrer old enough to cooperate undergo BX on 9 
occasions in the first 6 months after CTX and quarterly 
thereafter. Children too young to cooperate undergo BX with 
general anesthesia on 4 occasions in t e first 6 months after 
CTX and every 6 months thereafter. Additional biopsies are 
performed as warranted by symptoms or noninvasive tests. 
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ROLE OF ENDOMVCARDIAL BIOPSY REJECTION SURVEIL- 
LANCE IN PEDIATRIC CARDIAC TRANSPLANTATION 
Vincent Zales, Susan Crawford, Carl Backer, Constantine Mav- 
roudis, D. Woodrow Benson, Jr., Children’s Memorial Hospital, 
Chicago, IL. 
This report describes our post-Cardiac transplantation (CT) 
rejection surveillance protocol. CT have been performed for 
neonates (Croup I, 8 pts; 6-35 days, mean = 181, and children 
(Croup II, 10 pts; 9.1-14 yrs, mean = 7). Post-CT immunosup- 
preasion consisted of cyclosporin, imuran, and prednisone. 
Prednisone was discontinued 6 months following CT in Group 
I, but continued in Group II. Non-invasive rejection surveillance 
included clinical exam, echocardiographic (Echo) left ventric- 
ular (LV) dimensions and function. Cardiac biopc;y was per- 
formed on an outpatient basis in Gr I and Cr II pts. Billinghams 
criteria were used to evaluate 4-8 biopsy samples. In Croup 
I, biopsy was performed quarterly for 1 yr, after weaning Pred- 
nisone. In Croup II, biopsy was performed 12 times in the 
first 6 months. Rejection was followed by weekly biopsy until 
resolution. In Croup I, 7 episodes of rejection in 3 pts were 
suspected by clinical exam (heart rate, and appetite changes) 
and treated in the first 60 days post-CT. Echo change in LV 
function was only seen in 1 rejection episode. In 6 pts, 8 biopsy 
were performed, all <9 kg, with no evidence of rejection. There 
were no complications. In Croup II, heart rate and Echo change 
in LV function was seen in 3 rejection episodes, but acute 
rejection was diagnosed in 11 of 140 biopsy in 9 pts. Because 
of a paucity of findings suggesting rejection during non-invasive 
rejection surveillance, biopsy must be utilized in the care 
of children post-CT. biopsy is safe and provides adequate 
tissue for reliable rejection scrrveillance. 
Treatable acute rejection was present in 12 BXS (7%); 
continuing or resolving rejection in 16 others (9%). 
Remaining BXS had no evidence of rejection (105 BXS, 60%), 
had infiltrates insurficient to treat (28 XS, 16%), were 
inadequate for diagnosis (14 BXS, 8%) or were consistent with 
ischemia (1 BX. 0.5%). During the first 6 postoperative months 
9,001 BXS were positive for rejection, 6 occurring on 
surveillance BX. After 6 months 3/75 BXS showed a new 
episode of rejection, none occurring on surveillance 5X. 
We conclude: 1) episodes of rejection are unusual with triple 
drug immunosuppression; 2) surveillance BXS in the first 6 
months after CTX may show unsuspected rejection; 3) routine 
surveillance BXS more than 6 months after CTX are unlikely to 
show rejection in the absence of symptoms or other tests. 
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Although acute transplant mortality is not affected by 
graft ischemic time up to 8 hours, the question of late 
graft function after long ischemia has not been answered. 
We compared cardiac function of 22 consecutive patients, 
11 had locally procured grafts (LPG) and 11 had distallv 
procured grafts (DPG). ischemic times were longer in DPG 
(287+60? min vs LPG (107+11) min (p<.OO?I. Mean follow- 
up psriod was 17 mos for-both groubs. Infants were 
evaluated by simultaneous ECHO and cardiac catheteri- 
zation. Load independent end-systolic wall stress 
(ESWS)/velocity of circum+erential fiber shortening CVcf) 
relationship was studied at rest and after increasing 
afterload with methoxamine infusion (20-80 mca/Ka/min). 
Results: 
Heart rate (b/min) 
LPG DFG ” PV 
114+10 1154 ic 
LV fractional shortening (XI 41;6 43T4 NS 
LV pre-ejec/ejec time ratio .272.07 
Vcf (circ/sec) 
.272.04 NS 
ESWS (gm/cm2) 
1.562.29 1.82.24 NS 
NS 
Mean PA pressure (mmtlg) 
75213 6826 
PA wedge (mmHg) 
1624 1422 NS 
0.05 
LVEDP (mmHg) 
10+2 822 
Cl (L/min/m2) 
10+2 8+2 co.01 
4.5i.8 3.7z.6 co.05 
The slope of relationship of ESWS/Vcf at various levels 
of aft-r-load was similar in both groups. Resting Cl was 
lower in DPG but LV filling pressure was also less. 
Conclusion: Prolonged ischemia associated with distal 
procurement does not impair late graft function post 
infant cardiac transplant. 
